51. Corrigendum: Malaria and the liver: immunological hide-and-seek or subversion of immunity from within?
- Author
-
Patrick Bertolino and David G. Bowen
- Subjects
Microbiology (medical) ,sporozoites ,Hide and seek ,Internet privacy ,Immunology ,lcsh:QR1-502 ,malaria ,CD8 T cells ,Biology ,Microbiology ,lcsh:Microbiology ,03 medical and health sciences ,0302 clinical medicine ,Immunity ,medicine ,Subversion ,LSEC ,030304 developmental biology ,0303 health sciences ,tolerance ,General Commentary ,business.industry ,medicine.disease ,Data science ,business ,Malaria ,030215 immunology - Abstract
During the pre-erythrocytic asymptomatic phase of malarial infection, sporozoites develop transiently inside less than 100 hepatocytes that subsequently release thousands of merozoites. Killing of these hepatocytes by cytotoxic T cells (CTLs) confers protection to subsequent malarial infection, suggesting that this bottleneck phase in the parasite life cycle can be targeted by vaccination. During natural transmission, although some CTLs are generated in the skin draining lymph nodes, they are unable to eliminate the parasite, suggesting that the liver is important for the sporozoite to escape immune surveillance. The contribution of the organ to this process is unclear. Based on the known ability of several hepatic antigen-presenting cells (APCs) to induce primary activation of CD8 T cells and tolerance, malarial antigens presented by both infected hepatocytes and/or hepatic cross-presenting APCs should result in tolerance. However, our latest model predicts that due to the low frequency of infected hepatocytes, some T cells recognizing sporozoite epitopes with high affinity should differentiate into CTLs. In this review, we discuss two possible models to explain why CTLs generated in the liver and skin draining lymph nodes are unable to eliminate the parasite: (1) sporozoites harness the tolerogenic property of the liver; (2) CTLs are not tolerized but fail to detect infected cells due to sparse infection of hepatocytes and the very short liver stage. We propose that while malaria sporozoites might use the ability of the liver to tolerize both naive and effector cells, they have also developed strategies to decrease the probability of encounter between CTLs and infected liver cells. Thus, we predict that to achieve protection, vaccination strategies should aim to boost intrahepatic activation and/or increase the chance of encounter between sporozoite-specific CTLs and infected hepatocytes.
- Published
- 2015
- Full Text
- View/download PDF